Perry W. Buffington – Psychopharmacology 2-Day Conference

[Instant Download] – Immediately deliver the download link after receiving the paymentPurchase Perry W. Buffington – Psychopharmacology 2-Day Conference courses at here with PRICE $439.99 $83Faculty:Perry W. BuffingtonDuration:12 Hours 12 MinutesFormat:Audio and VideoCopyright:Sep 14, 2017 Manual ZNM048500 (2.97 MB) 121 Pages Available after Purchase OutlineDAY ONEPSYCHOPHARMACOLOGYHistorical antecedents of modern psychopharmacologyDiagnostic issuesClarification of termsDrug metabolism concepts: pharmacokinetics & pharmacodynamicsDrug mechanism of actionPlacebo & NoceboPharmacotherapy vs. PharmacotherapyDeveloping highly effective collaborations with prescribersDEPRESSIVE DISORDERSBiogenic Amine, Cortisol, Down-Regulation, & Neurotropic HypothesesNeurochemistry of depressionTypes of anti-depressantsPreventing side effectsTardive Dysphoria: real or imagined?ANXIETY DISORDERS & OBSESSIVE COMPULSIVE DISORDERS & TRAUMA RELATED DISORDERSNeurochemistry of anxietyGAD, panic disorders, phobiasOCDPTSDPhysiological interventionsAnti-anxiety medicationsAnti-depressantsNon-pharmacologic optionsBenzodiazepines: risks and benefitsPreventing side effectsBIPOLAR DISORDERSNeurochemistryThe Bipolar Spectrum & DSM-5® ChangesMood stabilizersLithiumAnti-convulsants & neuromodulatorsTypical, atypical, & third-generation antipsychoticsEffective strategies for improving outcomes for clientsPSYCHOTIC DISORDERS/ SCHIZOPHRENIANeurochemistry of psychosis and schizophreniaAntipsychotic Medications:First generation (typical)Second generation (atypical)Managing side effectsExtrapyramidal symptoms and TDMetabolic problems- what blood tests are needed and whenPreventing Diabetes MellitusRecognizing hyperprolactinemia- and why you need to knowUse of atypical antipsychotics for multiple disordersLIMITATIONS OF THE RESEARCH & POTENTIAL RISKSDAY TWO ATTENTIONAL DISORDERSDifferential diagnosisNeurochemistry of ADHDTreatment controversiesSubstance abuse and ADHDStimulant medicationsNon-stimulant optionsPreventing side effectsSUBSTANCE ABUSE DISORDERSNeurochemistry of addictionNegative reinforcement & creation of habitsAlcoholCaffeineNicotineCannabisOpiatesPCP & KetamineMDMA (Ecstasy)Energy vs. Chill DrinksOver-the-counter & herbal psychopharmacologyAddiction treatmentsBehavioral addictionsSPECIAL POPULATIONSSpecialized guidelines for geriatric patientsDementia treatmentSlow vs. rapid metabolizers (genetic polymorphisms)TREATING CLIENTS PAINAcute vs. chronic painAlternatives to pharmacologyPain vs. depression: which comes first?ETHICS & PSYCHOPHARMACOLOGYHigh-risk pharmacology & psychopharmacologyOff-label use of medicationsPrescribing for childrenElective psychopharmacologyMarketing of mental illnessPolypharmacyInformed vs. uninformed consentPatient & third party pressuresProfessional boundariesEthics associated with medical errorsRole of placeboFUTURE TRENDSChange of mind: preventing vs. managing side effectsMedicalization of normalComputer assisted devicesNew meds, new diagnoses, new theories, new normalTop 10 Medical EmergenciesIntegrating psychotherapy with psychopharmacologyLIMITATIONS OF THE RESEARCH & POTENTIAL RISKS FacultyPerry W. Buffington, PH.D., MS Related seminars and products: 2 Perry Buffington, Ph.D., M.S., has over 20 years of experience in the medical consulting field and is currently a full-time senior lecturer at the University of Georgia, teaching psychopharmacology at the undergraduate and graduate levels. He is former chairman of the prestigious Florida Psychological Association’s Prescriptive Authority Committee and teaches seminars nationwide on minimizing psychopharmacological errors. As the author of eight books (currently working on his first psychopharmacology text), his by-line has appeared in hundreds of periodicals including the Saturday Evening Post, USA Today, and Success. He is the former contributing editor for Delta Air Lines’ in-flight magazine, Sky, and served as a syndicated newspaper/web columnist for Universal Press. Additional, he hosted his own radio show, syndicated nationally, by Envison Radio Networks. Perry’s presentation style is engaging, a blend of education and entertainment; as a result, critics (and especially his students) applaud his ability to make complicated topics understandable and applicable – even useful!! Speaker Disclosures: Financial: Perry Buffington is the President of Go-Buff Enterprises, Inc. He is a member of the psychology faculty, Franklin College of Arts & Sciences, The University of Georgia. Dr. Buffington receives a speaking honorarium from PESI, Inc.Nonfinancial: Perry Buffington has no relevant nonfinancial relationship to disclose. Salepage: https://catalog.pesi.com//item/psychopharmacology-2day-conference-24536Archive: https://archive.ph/wip/TqeiFPurchase Perry W. Buffington – Psychopharmacology 2-Day Conference courses at here with PRICE $439.99 $83